anti-SRA1 (SRA1) Antikörper

Bezeichnung:
anti-Steroid Receptor RNA Activator 1 Antikörper (SRA1)
Auf www.antikoerper-online.de finden Sie aktuell 67 Steroid Receptor RNA Activator 1 (SRA1) Antikörper von 15 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen SRA1 Proteine (7) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 80 SRA1 Produkte verfügbar.
Synonyme:
AA959952, CD204, CMD1, CMPD1, E030028J09Rik, l(7)1Rl, l7Rl1, l71Rl, mKIAA0068, P140SRA-1, P140sra1, phSR1, phSR2, pl-1, pp7684, SCARA1, Shyc, SR-A, Sra, Sra-1, SRA1, Srap, Straa1, Strra1

Meistgesuchte Reaktivitäten zu anti-SRA1 (SRA1) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Mouse (Murine) SRA1 Antikörper:

anti-Human SRA1 Antikörper:

anti-Rat (Rattus) SRA1 Antikörper:

Alle verfügbaren anti-SRA1 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-SRA1 Antikörper

  1. Human Monoclonal SRA1 Primary Antibody für IHC (p), WB - ABIN1109138 : Lanz, Chua, Barron, Söder, DeMayo, OMalley: Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. in Molecular and cellular biology 2003 (PubMed)
    Zeige alle 3 Referenzen für 1109138

  2. Human Monoclonal SRA1 Primary Antibody für ELISA, IHC - ABIN2869196 : Chooniedass-Kothari, Hamedani, Troup, Hubé, Leygue: The steroid receptor RNA activator protein is expressed in breast tumor tissues. in International journal of cancer. Journal international du cancer 2006 (PubMed)
    Zeige alle 3 Referenzen für 2869196

  3. Human Polyclonal SRA1 Primary Antibody für IHC (p), IP - ABIN250657 : Khaleel, Dorheim, Duryee, Durbin, Bussey, Garvin, Klassen, Thiele, Anderson: High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure. in The Annals of thoracic surgery 2012 (PubMed)
    Zeige alle 2 Referenzen für 250657

  4. Human Monoclonal SRA1 Primary Antibody für IP, ELISA - ABIN1742561 : Bozdagi, Sakurai, Dorr, Pilorge, Takahashi, Buxbaum: Haploinsufficiency of Cyfip1 produces fragile X-like phenotypes in mice. in PLoS ONE 2012 (PubMed)
    Zeige alle 2 Referenzen für 1742561

Weitere Antikörper gegen SRA1 Interaktionspartner

Mouse (Murine) Steroid Receptor RNA Activator 1 (SRA1) Interaktionspartner

  1. Visfatin (zeige NAMPT Antikörper) upregulated CD36 (zeige CD36 Antikörper) and SRA (zeige MSR1 Antikörper) expression and downregulated ABCA1 (zeige ABCA1 Antikörper) and ABCG1 (zeige ABCG1 Antikörper) expression, subsequently increased ox-LDL uptake and decreased cholesterol efflux, and finally promoted foam cell formation via the PI3K- and ERK (zeige EPHB2 Antikörper)-dependent pathways.

  2. In Cyfip1 (zeige CYFIP1 Antikörper)-deficient mice, parental origin determines the impairment of synaptic functions and behavior.

  3. Data suggest that MAP kinase (zeige MAPK1 Antikörper)-interacting kinases (Mnk1 (zeige MKNK1 Antikörper), Mnk2 (zeige MKNK2 Antikörper)) regulate cell migration/wound healing, expression of vimentin (zeige VIM Antikörper), stability of vimentin (zeige VIM Antikörper) protein, and binding of cytoplasmic eIF4E (eukaryotic translation initiation factor 4E (zeige EIF4E Antikörper)) and Cyfip1 (zeige CYFIP1 Antikörper).

  4. The results of this study demonstrated that SRA (zeige MSR1 Antikörper) could attenuate microglia mediated inflammation injury in ICH (zeige ACE Antikörper). In addition, SRA (zeige MSR1 Antikörper) mediated negative feedback mechanism in neuroimmune homeostasis.

  5. these data are the first to indicate a functional role for SRA (zeige MSR1 Antikörper) in adipose tissue biology and glucose homeostasis in vivo.

  6. CYFIP2 (zeige CYFIP2 Antikörper) is a key regulator of cocaine response in mammals and present a framework to use mouse substrains to identify previously unknown genes and alleles regulating behavior.

  7. This study demonistrated that CYFIP1 (zeige CYFIP1 Antikörper) coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formation.

  8. haploinsufficiency of Cyfip1 (zeige CYFIP1 Antikörper) mimics key aspects of the phenotype of Fmr1 (zeige FMR1 Antikörper) knockout mice and are consistent with the hypothesis that these effects are mediated by interaction of Cyfip1 (zeige CYFIP1 Antikörper) and Fmrp (zeige FMR1 Antikörper) in regulating activity-dependent translation.

  9. Dax1 (zeige NR0B1 Antikörper) augmentation of LRH-1 (zeige NR5A2 Antikörper)-mediated Oct4 (zeige POU5F1 Antikörper) activation is dependent upon steroid receptor (zeige ESR2 Antikörper) RNA activator

  10. DEAD-box RNA helicase (zeige DDX56 Antikörper) p68 (DDX5 (zeige DDX5 Antikörper)) and its associated noncoding RNA, steroid receptor (zeige ESR2 Antikörper) RNA activator (SRA (zeige MSR1 Antikörper)), form a complex with CTCF (zeige CTCF Antikörper) that is essential for insulator function

Human Steroid Receptor RNA Activator 1 (SRA1) Interaktionspartner

  1. These findings suggest that SOX9 (zeige SOX9 Antikörper) may play an important role in tumor progression of Renal Cell Carcinoma (zeige MOK Antikörper) and Bladder Cancer and it may be used as a biomarker of this malignancy.

  2. Loss of DDRGK1 decreases SOX9 (zeige SOX9 Antikörper) expression and causes a human skeletal dysplasia.

  3. The expression of EVI1 (zeige MECOM Antikörper) and SOX9 (zeige SOX9 Antikörper) is associated with stem cell-like and metastasis signatures, and their depletion impairs the metastatic potential of breast cancer cells. These results establish the mechanistic link between resistance to mTOR (zeige FRAP1 Antikörper) inhibition and cancer metastatic potential, thus enhancing our understanding of mTOR (zeige FRAP1 Antikörper) targeting failure

  4. regulation of cancer stem cell via SLUG (zeige SNAI2 Antikörper)-SOX9 (zeige SOX9 Antikörper) regulatory axis

  5. data indicate that SOX9 (zeige SOX9 Antikörper) expression drives prostate cancer by reactivating the WNT (zeige WNT2 Antikörper)/beta-catenin (zeige CTNNB1 Antikörper) signaling that mediates ductal morphogenesis in fetal prostate and define a subgroup of patients who would benefit from WNT (zeige WNT2 Antikörper)-targeted therapy.

  6. Low levels of SOX9 (zeige SOX9 Antikörper) in primary stage II colon tumors predicts high risk of relapse.

  7. ELF3 (zeige ELF3 Antikörper) interacts directly with the HMG (zeige SSRP1 Antikörper) domain of Sox9 (zeige SOX9 Antikörper). Importantly, overexpression of ELF3 (zeige ELF3 Antikörper) significantly decreased Sox9 (zeige SOX9 Antikörper)/CBP (zeige CREBBP Antikörper)-dependent HAT (zeige MGEA5 Antikörper) activity.

  8. SR-A1 suppresses lung cancer metastasis by downregulating SAA1 (zeige SAA1 Antikörper) production in tumor-associated macrophages (TAM (zeige CCNA1 Antikörper)).

  9. PTX2 (zeige APCS Antikörper) was identified PTX2 (zeige APCS Antikörper) as a novel partner for FX, and both proteins cooperated to prevent their SR-AI (zeige MSR1 Antikörper)-mediated uptake by macrophages.

  10. SOX9 (zeige SOX9 Antikörper) is required for chondrogenesis: it secures chondrocyte lineage commitment, promotes cell survival, and transcriptionally activates the genes for many cartilage-specific structural components and regulatory factors.

SRA1 Antigen-Profil

Beschreibung des Gens

Both long non-coding and protein-coding RNAs are transcribed from this gene, and they represent alternatively spliced transcript variants. This gene was initially defined as a non-coding RNA, which is a coactivator for several nuclear receptors (NRs) and is associated with breast cancer. It has now been found that this gene is involved in the regulation of many NR and non-NR activities, including metabolism, adipogenesis and chromatin organization. The long non-coding RNA transcripts interact with a variety of proteins, including the protein encoded by this gene. The encoded protein acts as a transcriptional repressor by binding to the non-coding RNA.

Alternative names and synonyms associated with SRA1

  • cytoplasmic FMR1 interacting protein 1 (Cyfip1) Antikörper
  • macrophage scavenger receptor 1 (MSR1) Antikörper
  • SRY (sex determining region Y)-box 9 (SOX9) Antikörper
  • steroid receptor RNA activator 1 (SRA1) Antikörper
  • steroid receptor RNA activator 1 (Sra1) Antikörper
  • AA959952 Antikörper
  • CD204 Antikörper
  • CMD1 Antikörper
  • CMPD1 Antikörper
  • E030028J09Rik Antikörper
  • l(7)1Rl Antikörper
  • l7Rl1 Antikörper
  • l71Rl Antikörper
  • mKIAA0068 Antikörper
  • P140SRA-1 Antikörper
  • P140sra1 Antikörper
  • phSR1 Antikörper
  • phSR2 Antikörper
  • pl-1 Antikörper
  • pp7684 Antikörper
  • SCARA1 Antikörper
  • Shyc Antikörper
  • SR-A Antikörper
  • Sra Antikörper
  • Sra-1 Antikörper
  • SRA1 Antikörper
  • Srap Antikörper
  • Straa1 Antikörper
  • Strra1 Antikörper

Bezeichner auf Proteinebene für SRA1

cytoplasmic FMR1-interacting protein 1 , specifically Rac1-associated protein 1 , macrophage acetylated LDL receptor I and II , macrophage scavenger receptor type III , macrophage scavenger receptor types I and II , scavenger receptor class A member 1 , scavenger receptor class A, member 1 , SRY (sex-determining region Y)-box 9 protein , SRY-related HMG-box, gene 9 , transcription factor SOX-9 , steroid receptor RNA activator 1 (complexes with NCOA1) , steroid receptor RNA activator protein , steroid receptor coactivator , SRAP

GENE ID SPEZIES
20430 Mus musculus
4481 Homo sapiens
6662 Homo sapiens
10011 Homo sapiens
24068 Mus musculus
252891 Rattus norvegicus
Ausgewählte Anbieter für anti-SRA1 (SRA1) Antikörper
Haben Sie etwas anderes gesucht?